🇺🇸 FDA
Pipeline program

Bioequivalence of Lenvatinib 10 mg Capsules versus Lenvima® 10 mg Capsules in Healthy Participants Under Fasting Conditions.

BLCL-LEN-EU-01

Phase 1 other active

Quick answer

Bioequivalence of Lenvatinib 10 mg Capsules versus Lenvima® 10 mg Capsules in Healthy Participants Under Fasting Conditions. for No medical condition. is a Phase 1 program (other) at Pharma Mar S.A. with 1 ClinicalTrials.gov record(s).

Program details

Company
Pharma Mar S.A.
Indication
No medical condition.
Phase
Phase 1
Modality
other
Status
active

Clinical trials